8 Analysts Have This to Say About Humana
Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:
Oppenheimer Maintains Outperform Rating for Humana: Here’s What You Need To Know
Oppenheimer has decided to maintain its Outperform rating of Humana (NYSE:HUM) and raise its price target from $520.00 to $550.00.
Shares of Humana are trading down 0.25% over the last 24 hours, at $495.99 per share.
A move to $550.00 would account for a 10.89% increase from the current share price.
Truist Securities Maintains Hold on Humana, Raises Price Target to $570
Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the price target from $550 to $570.
HCA Healthcare To Surge About 20%, Plus This Analyst Increases PT On Netflix
Raymond James raised the price target for HCA Healthcare, Inc. (NYSE: HCA) from $230 to $250. HCA Healthcare shares rose 0.4% to close at $208.97 on Thursday.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday’s Mid-Day Session
Gainers
HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
This Is What Whales Are Betting On Humana
Someone with a lot of money to spend has taken a bearish stance on Humana (NYSE:HUM).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Netflix, Humana And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Nasdaq dropping around 70 points on Thursday. Here are some big stocks recording gains in today’s session.
Expert Ratings for Humana
Within the last quarter, Humana (NYSE:HUM) has observed the following analyst ratings: